AI assistant
Zai Lab Ltd — Director's Dealing 2023
Apr 5, 2023
31208_dirs_2023-04-05_b2abf291-23cc-4d52-81b5-52c0ea2dbfb0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2023-04-03
Reporting Person: Edmondson Frazor Titus III (Chief Legal Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-03 | Stock Options (Right to Buy) | $33.95 | A | 105669 | Acquired | 2033-04-03 | American Depositary Shares (105669) | Direct |
| 2023-04-03 | Restricted Share Units | $ | A | 20126 | Acquired | American Depositary Shares (20126) | Direct |
Footnotes
F1: The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer.
F2: The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.
F3: Each ADS represents ten Ordinary Shares of the issuer.
F4: Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer.
F5: The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting.